These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10657867)

  • 1. Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
    Bennett CL; Stinson TJ; Lane D; Amylon M; Land VJ; Laver JH
    Med Pediatr Oncol; 2000 Feb; 34(2):92-6. PubMed ID: 10657867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
    N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
    Larson RA; Dodge RK; Linker CA; Stone RM; Powell BL; Lee EJ; Schulman P; Davey FR; Frankel SR; Bloomfield CD; George SL; Schiffer CA
    Blood; 1998 Sep; 92(5):1556-64. PubMed ID: 9716583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study.
    Laver J; Amylon M; Desai S; Link M; Schwenn M; Mahmoud H; Shuster J
    J Clin Oncol; 1998 Feb; 16(2):522-6. PubMed ID: 9469336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
    Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
    Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL.
    Little MA; Morland B; Chisholm J; Hole A; Shankar A; Devine T; Easlea D; Meyer LC; Pinkerton CR
    Med Pediatr Oncol; 2002 Feb; 38(2):98-103. PubMed ID: 11813173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs.
    Bassan R; Lerede T; Di Bona E; Rossi G; Pogliani E; Rambaldi A; Buelli M; Viero P; Rodeghiero F; Izzi T; Corneo G; Barbui T
    Leuk Lymphoma; 1997 Jun; 26(1-2):153-61. PubMed ID: 9250800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia.
    Clarke V; Dunstan FD; Webb DK
    Med Pediatr Oncol; 1999 May; 32(5):331-5. PubMed ID: 10219333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
    Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
    Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
    Blood; 1996 Apr; 87(8):3143-50. PubMed ID: 8605328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.
    Delorme J; Badin S; Le Corroller AG; Auvrignon AA; Auclerc MF; Gandemer V; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Berthou C; Bauduer F; Pautard B; Vannier JP; Braguer D; Leblanc T; Leverger G; Baruchel A; Michel G
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):441-7. PubMed ID: 12794521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.
    Lee SM; Radford JA; Dobson L; Huq T; Ryder WD; Pettengell R; Morgenstern GR; Scarffe JH; Crowther D
    Br J Cancer; 1998 Apr; 77(8):1294-9. PubMed ID: 9579836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective and randomized comparison of early versus delayed prophylactic administration of granulocyte colony-stimulating factor (filgrastim) in children with cancer.
    Rahiala J; Perkkiö M; Riikonen P
    Med Pediatr Oncol; 1999 May; 32(5):326-30. PubMed ID: 10219332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.
    Ottmann OG; Hoelzer D; Gracien E; Ganser A; Kelly K; Reutzel R; Lipp T; Busch FW; Schwonzen M; Heil G
    Blood; 1995 Jul; 86(2):444-50. PubMed ID: 7541660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer.
    Riikonen P; Rahiala J; Salonvaara M; Perkkiö M
    Stem Cells; 1995 May; 13(3):289-94. PubMed ID: 7542114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
    Geissler K; Koller E; Hubmann E; Niederwieser D; Hinterberger W; Geissler D; Kyrle P; Knöbl P; Pabinger I; Thalhammer R; Schwarzinger I; Mannhalter C; Jaeger U; Heinz R; Linkesch W; Lechner K
    Blood; 1997 Jul; 90(2):590-6. PubMed ID: 9226158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
    J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
    Griffiths RI; Barron RL; Gleeson ML; Danese MD; O'Hagan A; Chia VM; Legg JC; Lyman GH
    Pharmacoeconomics; 2012 Feb; 30(2):103-18. PubMed ID: 21967155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
    Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.